FDA Approved: ZYCUBO — Original Application (Sentynl Therapeutics, Inc.)

View source ↗

Summary

FDA approved ZYCUBO (copper histidinate) in an original application from Sentynl Therapeutics for treatment of copper deficiency associated with Menkes disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menkes Disease

Drugs mentioned

• ZYCUBO (copper histidinate)

Snippet

ORIG AP for ZYCUBO (COPPER HISTIDINATE)